News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
The role of ADCs in the treatment of patients with Breast Cancer Brain Metastases – Dana-Farber’s Breast Oncology Center
nfcr.org
Dec 8, 2024, 06:53

The role of ADCs in the treatment of patients with Breast Cancer Brain Metastases – Dana-Farber’s Breast Oncology Center

Dana-Farber’s Breast Oncology Center shared a post on X, about a recent paper by Stacey Pan et al. published in Sage Journals.

“Check out this recent review on the role of Antibody Drug Conjugates in the treatment of patients with Breast Cancer Brain Metastases.”

“Role of antibody-drug conjugates in the treatment of patients with breast cancer brain metastases”

Authors: Stacey Pan, Jayant Gadrey, Sarah Sammons, Nancy Lin, Sara Tolaney, Paolo Tarantino, Ilana Schlam.

The role of ADCs in the treatment of patients with Breast Cancer Brain Metastases - Dana-Farber’s Breast Oncology Center

More posts featuring Dana-Farber’s Breast Oncology Center.

ADCs Antibody drug conjugates Breast Cancer Brain Metastases cancer Dana-Farber’s Breast Oncology Center Ilana Schlam Jayant Gadrey Nancy Lin OncoDaily Oncology Paolo Tarantino Sara Tolaney Sarah Sammons Stacey Pan
Special Coverage
Science
Jan 3, 2025, 16:58
Emmanuel S. Antonarakis: The two faces of FOXA1 mutations in prostate cancers
Science
Jan 3, 2025, 16:56
Richa Shah: My Forever Paper
Science
Jan 3, 2025, 16:51
Melinda Bachini: Advancing Patient-Centered Care in Transplant Oncology
Blog
Jan 3, 2025, 16:48
The NCI Cellular Cancer Biology Imaging Research Program
Blog
Jan 3, 2025, 16:40
Call for nominations for 2025 Arthur M. Sutherland Award and Memorial Lecture - IPOS
Career
Jan 3, 2025, 16:33
Amy de Haar-Holleman started as a Clinical Professor at Free University of Brussels
Science
Jan 3, 2025, 16:25
Amivantamab Plus Lazertinib in Patients With EGFR-mutant NSCLC by Benjamin Besse et al.
Science
Jan 3, 2025, 16:22
Expert consensus statement on the peri-operative management of NSCLC by Stephanie Saw et al.
Science
Jan 3, 2025, 16:17
Iannis Aifantis: Our short review/discussion of the Comazzetto and Morrison Ascorbate deficiency
Blog
Jan 3, 2025, 16:13
Early registration for GU25 closes on January 8th - ASCO
Blog
Jan 3, 2025, 15:57
High peripheral T cell diversity associated with lower risk of toxicity to dual ICI Therapy - JITC
Blog
Jan 3, 2025, 15:31
Gaia Griguolo: TOP1 Mutations are more frequent after treatment with ADCs